Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Lobby Group Supports Use Of DPA To Ramp Up PPE Production

Executive Summary

In a letter to US Vice President Mike Pence, AdvaMed says it supports the federal government using its broad legal authority under the Defense Production Act to mandate increased production of personal protective equipment for outpatient physicians and health care workers. However, it cautioned the government should use the law to facilitate production rather than to take over medtech manufacturing firms.

You may also be interested in...



AdvaMed: Medtech Industry Wants Seat At Biden’s Coronavirus Response Table

The largest medical device lobby group in the US says it’s open to the administration’s decision to invoke the Defense Production Act to boost testing and PPE production, but wants to be consulted on how to implement it.

Biden Will Invoke Defense Production Act On ‘Day One’ To Ramp Up PPE Manufacture

So says infectious diseases physician Celine Gounder, who’s a member of the US president-elect’s COVID-19 task force.

Trump Should Have Focused On National COVID-19 Testing Plan, US House Says In ‘Failure To Lead’ Report

President Trump has failed to use appropriate legal authorities to fight the coronavirus, US House leaders say in a new report.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel